Consistent with these previous reports, we demonstrated that high levels of PTEN were related to sensitivity to sunitinib in tumors from CCRCC patients, PDX models, and CCRCC cell lines. This evidence concerns the gene PTEN and nonpapillary renal cell carcinoma.